IIKBS Plays Key Scientific Role in International MOVE Protocol Study, Validating Advanced Biomechanics in Clinical Rehabilitation

The study, which commenced in June 2024, brought together a consortium of elite institutions from India and the United States to investigate a novel, activity-based approach to musculoskeletal pain. With a total of 40 participants, the research has delivered compelling evidence that an early, progressive movement protocol is superior to traditional passive rest, leading to faster recovery times and improved functional outcomes.

IIKBS played a unique and critical role in the study’s success. While other sites focused on participant recruitment and protocol delivery, the IIKBS team, led by Site Principal Investigator Dr. Anya Petrova, M.D., Ph.D. (Sports Medicine), was responsible for the crucial task of applied biomechanics testing and data validation. The institute managed a cohort of 9 participants, leveraging its state-of-the-art labs and scientific expertise to ensure the integrity and accuracy of the study’s complex datasets.

"At IIKBS, our mission is to bridge the gap between fundamental science and real-world application. Our involvement in the MOVE Protocol study is a perfect embodiment of that mission," said Dr. Anya Petrova. "Our role was not merely to collect data, but to validate it, to ensure that the functional improvements being reported were underpinned by genuine, measurable changes in movement quality and biomechanical efficiency. We are proud to have provided the scientific backbone for this study, reinforcing the principle that objective measurement is the bedrock of credible clinical research."

The collaborative efforts of all four sites—MMSx Authority (USA), BodyGNTX (USA), GFFI (India), and IIKBS (India)—produced a unified and powerful set of results. The study’s primary findings demonstrated significant improvements in pain and function for patients with acute and subacute musculoskeletal conditions.

These results were achieved with an outstanding safety profile, with no serious adverse events reported, and a high degree of patient engagement, reflected in an 82% median adherence rate. The findings provide a strong evidence-based rationale for shifting clinical practice towards early and structured mobilization.

IIKBS’s participation in the MOVE Protocol study highlights its central role in the global movement science ecosystem. By providing the critical layer of biomechanical validation, the institute has helped to ensure that the study’s groundbreaking findings are built on a foundation of impeccable scientific rigor.

This research will be disseminated through the affiliated MMSx Journal of Movement Mechanics & Biomechanics, contributing to the open science mission shared by IIKBS and its strategic partners. The findings will also be integrated into the institute’s advanced curriculum, from its specialized diplomas to its Ph.D. and post-doctoral programs, training the next generation of researchers and clinicians in the latest evidence-based protocols.

The MOVE Protocol study is a powerful example of how multi-disciplinary, international collaboration can accelerate scientific progress. IIKBS is proud to have been a key scientific pillar in this endeavor, reinforcing its commitment to advancing human movement science through heritage research and modern clinical impact.